Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Music City Nuclear Pharmacy was a specialized radiopharmaceutical service provider based in Nashville, Tennessee. The company focused on the compounding, preparation, and distribution of radioactive diagnostic and therapeutic agents used in nuclear medicine, such as SPECT and PET imaging. It served a network of hospitals and diagnostic clinics in the Nashville metropolitan area, providing unit-dose radiopharmaceuticals for various medical procedures. The company was a member of the United Pharmacy Partners (UPPI) network before its operations were integrated into a larger national provider following its acquisition. Its radioactive materials license was officially terminated in 2019 as part of its consolidation into the acquirer's network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Music City Nuclear Pharmacy.